Study guide
15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System
Philippine Medical Technologists Licensure Examination MTLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety
1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards
2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function
2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice
3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology
3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology
4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety
4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms
5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria
5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology
6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology
6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods
7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods
7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control
8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders
8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry
9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders
9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests
10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing
10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures
11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions
11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin
12 Chapter 12: Clinical Serology and Immunology
12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)
13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology
13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control
14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens
14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens
15 Chapter 15: Histopathologic Techniques and Cytotechnology
15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records
16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics
16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics
15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System
Key Takeaways Explain This Topic AI
Cytology specimens are exfoliative, abrasive, washings, or fine-needle aspirates, and liquid-based preparations allow high-risk HPV testing from the same vial.
Papanicolaou smears must be wet-fixed immediately in 95% ethanol or a spray fixative, because air-drying swells cells and smudges chromatin.
The Papanicolaou stain uses five dyes in three solutions: hematoxylin for nuclei, OG-6 for keratin, and EA (eosin Y, light green SF, and Bismarck brown) for cytoplasm.
Under the Bethesda System, LSIL includes HPV cytopathic effect (koilocytes) and CIN 1, while HSIL includes CIN 2, CIN 3, and carcinoma in situ.
Malignant cells show a high N:C ratio, hyperchromasia, coarse irregular chromatin, irregular nuclear membranes, prominent nucleoli, and loss of cohesion.
Last updated: October 2026
Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System
Cytology carries 10% of the histopathologic techniques portion of the board blueprint. Cytology examines individual cells and small clusters rather than intact tissue architecture, so the quality of collection, immediate fixation, and staining decides whether a diagnosis is possible. This section covers specimen types and collection methods, fixation, the Papanicolaou stain, Bethesda reporting for cervical cytology, non-gynecologic and hormonal cytology, and the cytologic criteria of malignancy.
1. Specimen Types and Collection Methods
Method How Cells Are Obtained Examples
Exfoliative Cells shed naturally into body fluids or secretions Voided urine, sputum, pleural and peritoneal effusions, CSF
Abrasive Cells scraped or brushed from a surface Cervical spatula and cytobrush or broom sampling, bronchial and esophageal brushings
Washings / lavage Saline instilled and recovered Bronchial washings, bronchoalveolar lavage, bladder washings
Fine-needle aspiration (FNA) Cells aspirated through a thin needle (commonly 22 to 25 gauge) Thyroid nodules, breast lumps, lymph nodes, superficial masses
Conventional cervical smears are spread thinly and fixed at once. Liquid-based cytology rinses the sampling device into a preservative vial; the processor removes much of the blood and mucus and produces a thin layer of cells, and the residual fluid can be used for high-risk HPV testing.
Cervical cancer screening combines cytology with testing for high-risk human papillomavirus (HPV), particularly types 16 and 18, the main cause of cervical carcinoma.
2. Fixation, Papanicolaou Staining, and the Bethesda System
Cytopathology examines exfoliated or fine-needle aspirated cells. Fixation and staining must prevent air-drying artifacts to preserve subtle chromatin patterns.
Fixation and Papanicolaou (Pap) Staining Method
Wet Fixation : Cervical smears must undergo immediate immersion in 95% ethyl alcohol within 2 to 3 seconds of smear generation. Allowing smears to air-dry prior to alcohol immersion causes air-drying artifact —marked cellular swelling, nuclear smudging, and loss of chromatin detail.
The Papanicolaou Staining Formulation : Utilizes five dyes formulated into three separate solutions :
Harris Hematoxylin : Nuclear stain highlighting hyperchromasia, nuclear membrane grooving, and chromatin distribution.
Orange G-6 (OG-6) : Monochrome acidic counterstain dissolved with phosphotungstic acid. Specifically stains keratin a brilliant, intense orange , identifying mature keratinized squamous cells and abnormal keratinized squamous cell carcinomas.
Eosin Azure (EA-50 or EA-36) : Polychrome mixture containing:
Eosin Y : Stains cytoplasm of mature superficial squamous cells, nucleoli, and red blood cells bright pink.
Light Green SF Yellowish : Stains cytoplasm of metabolically active intermediate cells, parabasal cells, endocervical columnar cells, and malignant cells blue-green to cyan .
Bismarck Brown Y : Historically added; binds mucins (often omitted in modern modified formulations without diagnostic loss).
The Bethesda System for Reporting Cervical Cytology
Standardized diagnostic nomenclature for cervical cytology:
Specimen Adequacy : Satisfactory for evaluation (estimated minimum 8,000–12,000 well-preserved squamous cells on conventional smears or 5,000 cells on liquid-based preparations). The presence or absence of an endocervical/transformation zone component is reported as a quality indicator, but its absence alone does not make a specimen unsatisfactory.
Negative for Intraepithelial Lesion or Malignancy (NILM) : Normal cellular flora ( Lactobacillus ), reactive inflammatory changes, atrophy.
Atypical Squamous Cells (ASC) :
ASC-US : Atypical Squamous Cells of Undetermined Significance.
ASC-H : Atypical Squamous Cells, cannot exclude High-grade intraepithelial lesion.
Low-Grade Squamous Intraepithelial Lesion (LSIL) : Encompasses transient Human Papillomavirus (HPV) cytopathic effect and Cervical Intraepithelial Neoplasia Grade 1 (CIN-1). Hallmark: Koilocytes —enlarged hyperchromatic nuclei surrounded by a sharply demarcated, clear perinuclear halo with condensed peripheral cytoplasmic rims.
High-Grade Squamous Intraepithelial Lesion (HSIL) : Encompasses CIN-2, CIN-3, and Carcinoma in Situ (CIS). Characterized by high nuclear-to-cytoplasmic (N:C) ratios, nuclear membrane irregularity, marked hyperchromasia, and loss of squamous differentiation.
Squamous Cell Carcinoma : Invasive malignancy, often with keratinized "tadpole" or fiber cells, tumor diathesis (necrotic debris and old blood), and prominent nucleoli.
Glandular Cell Abnormalities : Atypical glandular cells (AGC: endocervical, endometrial, or not otherwise specified), AGC favor neoplastic, endocervical adenocarcinoma in situ (AIS), and adenocarcinoma.
Non-Gynecologic and Hormonal Cytology
Fixation choices: Smears for Papanicolaou staining are wet-fixed in 95% ethanol or with a spray/coating fixative (alcohol plus polyethylene glycol, sprayed from about 10 to 15 cm). Air-dried smears are reserved for Romanowsky-type stains such as Diff-Quik, which are common for rapid on-site evaluation of fine-needle aspirates.
Fluid specimens: Urine, effusions, cerebrospinal fluid, and washings are concentrated by cytocentrifugation (cytospin), membrane filtration, or liquid-based preparation. A cell block (the centrifuged pellet clotted with plasma-thrombin or embedded in agar, then processed like tissue) allows sections for special stains and immunohistochemistry.
Maturation index: Hormonal cytology counts 100 squamous cells and reports parabasal, intermediate, and superficial percentages (written in that order). Estrogen pushes the count toward superficial cells, progesterone toward intermediate cells, and atrophy toward parabasal cells.
Sex chromatin (Barr body): The inactivated X chromosome appears as a dense plano-convex body against the nuclear membrane of buccal squamous cells. The number of Barr bodies is one less than the number of X chromosomes.
3. Cytologic Criteria of Malignancy
No single feature proves malignancy; cytotechnologists weigh several together.
Nuclear enlargement and a high nuclear-to-cytoplasmic (N:C) ratio.
Hyperchromasia with coarse, irregularly distributed chromatin .
Irregular nuclear membranes (notches, grooves, folds) and multiple or enlarged, irregular nucleoli .
Pleomorphism (variation in cell and nuclear size and shape) and abnormal mitoses .
Loss of cohesion , producing many single atypical cells, and a tumor diathesis (necrotic debris and old blood) in the background of invasive cancers.
Reactive and repair changes can mimic malignancy: nuclei may enlarge and nucleoli may be prominent, but the chromatin stays fine and evenly distributed, the nuclear membranes stay smooth, and the cells stay cohesive in flat sheets.